Will CRISPR Stock Rebound After A 10% Fall In A Week?
- Friday, July 9, 2021, 7:14
- Market
- Add a comment
The stock price of CRISPR Therapeutics, a biotechnology gene editing company focused on developing gene-based medicines for human diseases, reached an all-time high of $210 in January of this year before a larger sell-off in the gene-editing companies drove the stock price down nearly 32% to its…
About the Author
admin123 has written 23527 stories on this site.
